Program Policies & Procedures

This guide includes best opportunities for driving improvements in opioid stewardship within their organization and community.

This guide helps health care providers, systems, and communities support recovery from substance use disorders via employment mechanisms. 

This web page provides frequently asked questions regarding the 2023 Consolidated Appropriations Act, which eliminates the X-waiver (DATA-Waiver) and increases accessibility of medication-assisted treatment (MAT).

This guidance document provides information regarding issuance of updated DEA registration certificates to reflect Congress’s elimination of the X-waiver (DATA-Waiver) in the Consolidated Appropriations Act of 2023, increasing accessibility of medication-assisted treatment (MAT).

This letter announces details on Congress's elimination of the X-waiver (DATA-Waiver) to increase buprenorphine accessibility in the Consolidated Appropriations Act of 2023, increasing accessibility of medication-assisted treatment (MAT).

This guide focuses on using medication-assisted treatment for opioid use disorder in jails and prisons and during the reentry process when justice-involved persons return to the community. 

This report summarizes barriers and facilitators to providing MOUD at FQHCs and outlines opportunities at the health center, state, and federal level to support the clinical, organizational, and financial capacity to increase access to MOUD.

This case study explores implementation of a medications for opioid use disorder (MOUD) program at an organization in the Bronx, New York with a long history as an opioid treatment program (OTP) that also operates an FQHC and a certified community behavioral health clinic (CCBHC)

This case study explores implementation of medications for opioid use disorder (MOUD) through a federally qualified health center (FQHC) serving as a Health Care for the Homeless (HCH) program in Portland, Maine.

This case study explores implementation of medications for opioid use disorder (MOUD) at a federally qualified health center (FQHC) in rural California that engages with the broader community to address the opioid epidemic.